CDKN2A but not TP53 mutations nor HPV presence predict poor outcome in metastatic squamous cell carcinoma of the skin

MLA

Heidi V.N. Küsters-Vandevelde, et al. “CDKN2A but Not TP53 Mutations nor HPV Presence Predict Poor Outcome in Metastatic Squamous Cell Carcinoma of the Skin.” International Journal of Cancer, vol. 126, Jan. 2010, pp. 2123–32. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f79aebdd20b995702c87234fd6216c14&authtype=sso&custid=ns315887.

APA

Heidi V.N. Küsters-Vandevelde, Willeke A. M. Blokx, Wim Quint, Marian A. J. Verdijk, Willem J. G. Melchers, Maurits N. C. de Koning, Marjolijn J L Ligtenberg, & Arjanne Van Leeuwen. (2010). CDKN2A but not TP53 mutations nor HPV presence predict poor outcome in metastatic squamous cell carcinoma of the skin. International Journal of Cancer, 126, 2123–2132.

Chicago

Heidi V.N. Küsters-Vandevelde, Willeke A. M. Blokx, Wim Quint, Marian A. J. Verdijk, Willem J. G. Melchers, Maurits N. C. de Koning, Marjolijn J L Ligtenberg, and Arjanne Van Leeuwen. 2010. “CDKN2A but Not TP53 Mutations nor HPV Presence Predict Poor Outcome in Metastatic Squamous Cell Carcinoma of the Skin.” International Journal of Cancer 126 (January): 2123–32. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f79aebdd20b995702c87234fd6216c14&authtype=sso&custid=ns315887.